Pa. Judge Explains Call To Keep $2.5M J&J Risperdal Verdict

Law360, Philadelphia (August 14, 2017, 4:09 PM EDT) -- A Pennsylvania state judge has explained his reason for denying a Johnson & Johnson unit’s request for a new trial over abnormal breast growth allegedly linked to the drug Risperdal, saying the company's “extraordinary” defense tactics warranted allowing an Alabama boy’s family to find a new expert witness during the case.

Judge Ramy Djerassi in the Philadelphia County Court of Common Pleas said Thursday that Janssen Pharmaceuticals Inc., which is currently appealing a $2.5 million verdict it was slapped with in the case, had waited until...
To view the full article, register now.